Kayne Anderson BDC, Inc. current report, 14 February 2024

Kayne Anderson BDC, Inc. — Form 8-K Summary

Business Context and Reporting Period

Kayne Anderson BDC, Inc. filed a Form 8-K covering an event dated February 14, 2024. The filing reports an unregistered issuance of common stock under existing subscription agreements. The report was signed on February 21, 2024.

Key Financial and Capital Metrics

  • Shares issued: 7,089,771 shares of common stock.
  • Aggregate offering price: $118.7 million.
  • Existing aggregate capital commitments: $1,046.9 million.
  • Underwriting fees: No underwriting discounts or commissions were paid or will be paid.
  • Revenue, profit, cash flow, margins, debt and liquidity: The filing does not provide financial statements or clear values for these metrics.

Material Changes Versus the Prior Comparable Period

The filing does not provide a prior-period comparison. The reported issuance increases the company’s equity capital and draws on commitments previously obtained from investors.

Outlook, Risks and Unusual Items

  • Investors are required to fund future drawdowns to purchase shares up to their respective capital commitments, with at least 10 days’ prior notice.
  • The issuance was made pursuant to subscription agreements and was exempt from Securities Act registration under Section 4(a)(2) and Regulation D.
  • The company relied in part on investor representations that each stockholder was an accredited investor.
  • No management guidance, operating outlook, contingencies, or additional risk commentary is provided.

Important Facts to Verify

  • Confirm the number of shares issued and the $118.7 million aggregate proceeds.
  • Assess the remaining availability under the $1,046.9 million of aggregate capital commitments.
  • Review the subscription agreements for drawdown conditions, notice requirements and investor funding obligations.
  • Confirm the accounting and balance-sheet impact of the issuance in the company’s next periodic financial report.
  • Verify the private-placement exemption and accredited-investor representations supporting the issuance.